A Aouba

Summary

Country: France

Publications

  1. doi Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospects
    Achille Aouba
    Department of Internal Medicine and the French Vasculitis Study Group, Assistance Publique Hopitaux de Paris, Universite Paris, 5 René Descartes, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75679, Paris Cedex 14, France
    Clin Rev Allergy Immunol 34:65-73. 2008
  2. ncbi [Pourfour du Petit syndrome: a rare aetiology of unilateral exophtalmos with mydriasis and lid retraction]
    A Aouba
    Service de Medecine Interne, Hopital Europeen Georges Pompidou, 20, rue Leblanc, 75908 Paris Cedex 15, France
    Rev Med Interne 24:261-5. 2003
  3. ncbi Hemophagocytic syndrome as a presenting sign of transformation of smoldering to acute adult T-cell leukemia/lymphoma: efficacy of anti-retroviral and interferon therapy
    Achille Aouba
    Department of Haematology, Hopital Necker Enfants Malades, Paris, France
    Am J Hematol 76:187-9. 2004
  4. ncbi Tricuspid aseptic endocarditis revealing right endomyocardial fibrosis during an unrecognized Behçet's disease. A case report
    Achille Aouba
    Department of Internal Medicine and Rheumatology, Hopital Europeen Georges Pompidou, Paris 75
    Presse Med 33:1367-9. 2004
  5. ncbi Severe pulmonary arterial hypertension as initial manifestation of intravascular lymphoma: case report
    Achille Aouba
    Department of Haematology, Hopital Necker Enfants Malades, Paris, France
    Am J Hematol 79:46-9. 2005
  6. doi Azathioprine or methotrexate maintenance for ANCA-associated vasculitis
    Christian Pagnoux
    Universite Paris Descartes, Hopital Cochin, Assistance Publique Hopitaux de Paris, Paris, France
    N Engl J Med 359:2790-803. 2008
  7. ncbi Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients
    B Brihaye
    French Vasculitis Study Group, Department of Internal Medicine, Hopital Cochin, Assistance Publique Hopitaux de Paris, Universite Paris 5 Rene Descartes, Paris, France
    Clin Exp Rheumatol 25:S23-7. 2007
  8. doi Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database
    Christian Pagnoux
    Universite Paris Descartes, Hopital Cochin, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 62:616-26. 2010
  9. pmc Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome
    Raphaele Seror
    Department of Rheumatology, Hopital Bicetre, Assistance Publique Hopitaux de Paris, Universite Paris Sud 11, INSERM U802, Le Kremlin Bicetre, France
    Ann Rheum Dis 66:351-7. 2007
  10. doi Screening for von Willebrand disease: contribution of an automated assay for von Willebrand factor activity
    D Lasne
    Laboratoire d Hematologie, Hopital Necker, AP HP, Paris, France
    Haemophilia 18:e158-63. 2012

Detail Information

Publications17

  1. doi Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospects
    Achille Aouba
    Department of Internal Medicine and the French Vasculitis Study Group, Assistance Publique Hopitaux de Paris, Universite Paris, 5 René Descartes, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75679, Paris Cedex 14, France
    Clin Rev Allergy Immunol 34:65-73. 2008
    ..This promising biotherapy opens the way for other therapeutic agents targeting B lymphocytes and to improve our understanding of the pathophysiology of ANCA-associated vasculitis...
  2. ncbi [Pourfour du Petit syndrome: a rare aetiology of unilateral exophtalmos with mydriasis and lid retraction]
    A Aouba
    Service de Medecine Interne, Hopital Europeen Georges Pompidou, 20, rue Leblanc, 75908 Paris Cedex 15, France
    Rev Med Interne 24:261-5. 2003
    ..Pourfour du Petit syndrome, rarely reported, is the opposite of Claude Bernard-Horner syndrome...
  3. ncbi Hemophagocytic syndrome as a presenting sign of transformation of smoldering to acute adult T-cell leukemia/lymphoma: efficacy of anti-retroviral and interferon therapy
    Achille Aouba
    Department of Haematology, Hopital Necker Enfants Malades, Paris, France
    Am J Hematol 76:187-9. 2004
    ..Thus, we propose that adult T-cell leukemia/lymphoma must be added to the spectrum of etiologies of hemophagocytic syndrome...
  4. ncbi Tricuspid aseptic endocarditis revealing right endomyocardial fibrosis during an unrecognized Behçet's disease. A case report
    Achille Aouba
    Department of Internal Medicine and Rheumatology, Hopital Europeen Georges Pompidou, Paris 75
    Presse Med 33:1367-9. 2004
    ..Aseptic endocarditis or/and endomyocardial fibrosis are rarely reported in Behçet's disease...
  5. ncbi Severe pulmonary arterial hypertension as initial manifestation of intravascular lymphoma: case report
    Achille Aouba
    Department of Haematology, Hopital Necker Enfants Malades, Paris, France
    Am J Hematol 79:46-9. 2005
    ..For this purpose, blood collected via pulmonary capillary-wedge aspiration for cytologic examination may be associated with right-sided heart catheterization when this latter procedure is suitable...
  6. doi Azathioprine or methotrexate maintenance for ANCA-associated vasculitis
    Christian Pagnoux
    Universite Paris Descartes, Hopital Cochin, Assistance Publique Hopitaux de Paris, Paris, France
    N Engl J Med 359:2790-803. 2008
    ..However, azathioprine and methotrexate have not been compared with regard to safety and efficacy...
  7. ncbi Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients
    B Brihaye
    French Vasculitis Study Group, Department of Internal Medicine, Hopital Cochin, Assistance Publique Hopitaux de Paris, Universite Paris 5 Rene Descartes, Paris, France
    Clin Exp Rheumatol 25:S23-7. 2007
    ..But the frequency of and time to responses to rituximab, and its effects on various clinical WG manifestations remain to be thoroughly evaluated...
  8. doi Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database
    Christian Pagnoux
    Universite Paris Descartes, Hopital Cochin, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 62:616-26. 2010
    ..This study was undertaken to describe the main characteristics of and long-term outcomes in patients with well-characterized PAN diagnoses...
  9. pmc Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome
    Raphaele Seror
    Department of Rheumatology, Hopital Bicetre, Assistance Publique Hopitaux de Paris, Universite Paris Sud 11, INSERM U802, Le Kremlin Bicetre, France
    Ann Rheum Dis 66:351-7. 2007
    ..To investigate the safety and efficacy of rituximab (RTX) for systemic symptoms in patients with primary Sjögren's syndrome (pSS), and changes in B cell biomarkers...
  10. doi Screening for von Willebrand disease: contribution of an automated assay for von Willebrand factor activity
    D Lasne
    Laboratoire d Hematologie, Hopital Necker, AP HP, Paris, France
    Haemophilia 18:e158-63. 2012
    ..Our findings support VWF:AC use for the diagnostic work-up of VWD, paying close attention to concomitant clinical signs and bleeding score, as recommended for VWD...
  11. ncbi [Crowned dens syndrome: three new cases]
    A Aouba
    Service de Medecine Interne, Hopital Foch, Suresnes, France
    Rev Med Interne 24:49-54. 2003
    ..We report on three new cases diagnosed from 1996 to 1999...
  12. doi Deaths associated with acquired haemophilia in France from 2000 to 2009: multiple cause analysis for best care strategies
    A Aouba
    INSERM, CépiDc, Le Kremlin Bicetre, France
    Haemophilia 18:339-44. 2012
    ..Moreover, as several of its DCD correspond also to steroids side effects, best tolerated immunosuppressant regimen with steroid-sparing agents adjoining are particularly awaited in AH population...
  13. ncbi Complete remission in refractory relapsing polychondritis with intravenous immunoglobulins
    B Terrier
    Department of Internal Medicine, Cochin Hospital, Assistance Publique Hopitaux de Paris, Universite Paris Descartes, Paris, France
    Clin Exp Rheumatol 26:136-8. 2008
  14. doi Rituximab reversed cardiac involvement of Wegener's granulomatosis: magnetic resonance imaging assessment
    Benoit Brihaye
    French Vasculitis Study Group, Department of Internal Medicine, AP HP, Hopital Cochin, Université Paris 5 Descartes, F 75679 Paris cedex 14, France
    Presse Med 37:412-5. 2008
    ..We report the disease course of a patient who received rituximab to treat cardiac involvement documented by contrast-enhanced cardiac magnetic resonance imaging (ceCMR)...
  15. doi Spumous histiocytic oligoarthritis coexisting with systemic Langerhans' cell histiocytosis: case report and literature review
    Achille Aouba
    Department of Internal Medicine, Referal Center for Histiocytosis, Hopital Cochin, Assistance Publique Hopitaux de Paris, Université de Paris 5 René Descartes, 27, rue du Faubourg Saint Jacques, 75679 Paris Cedex 14, France
    Joint Bone Spine 76:701-4. 2009
    ..Both entities regressed under cladribine, with only mild relapses of the non-Langerhans' cell histiocytosis involvements...
  16. ncbi [Behçet's disease]
    Achille Aouba
    Université de Paris5 René Descartes
    Rev Prat 58:533-40. 2008
    ....
  17. ncbi Intravascular lymphoma associated with haemophagocytic syndrome: a very rare entity in western countries
    Benjamin Terrier
    Department of Adult Haematology, Necker Hospital, 149 161 Rue de Sèvres, 75743 Paris Cedex 15, France
    Eur J Haematol 75:341-5. 2005
    ..Early recognition of IVL-HS by performing bone marrow biopsy is critical to start rapidly appropriate treatment. The role of rituximab in the management of IVL-HS remains to be established...